Ptc Therapeutics, Inc. · NASDAQ:PTCT

Klein Matthew B. sold 2,850 Ptc Therapeutics, Inc. shares (Form 4)

Traded Apr 21, 2026 · Filed Apr 23, 2026

On Apr 21, 2026, Klein Matthew B. (Director, CHIEF EXECUTIVE OFFICER) sold 2,850 Ptc Therapeutics, Inc. shares at US$70.91 for US$202K under a trading plan, leaving 394,070 shares. Filed Apr 23, 2026 (Form 4).

Sold
2,850 shares
Price
US$70.91
Value
US$202K
Holding after
394,070 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, CHIEF EXECUTIVE OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 21, 2026Common StockSale2,850US$70.91394,070Direct

Source

View original at SEC

Related